| Surgery |
|
#39
|
The
Role Of Ultrasonography To Evaluate Chest Wall Sarcomas
Nicola Fabbri, Italy
|
| #78 |
High-resolution
Intravascular Ultrasonography To Assess Vessel-invasiveness
Of Soft Tissue Sarcoma
Peter Hohenberger, Germany
|
| #48 |
Should
Soft Tissue Sarcomas Be Traeted At A Specialist Centre?
Robert Grimer, UK
|
| #55 |
Positive
Margins After Attempted Wide Excision Of A Soft Tissue Sarcoma:
Is Further Excision Necessary?
Edward Y. Cheng, USA
|
| #19 |
Dedifferentiated
Chondrosarcoma: Updated Outcomes With Current Treatment Approaches
As Compared To Those Prior To 1984
Sean Scully, USA
|
| #50 |
Desmoid
Tumors. A Clinical Review Of 30 Patients With More Than 20
Years Follow-up
Mikael Dalén, Sweden
|
| #40 |
Approach
To Prosthetic Reconstruction In Sternal Sarcoma
Nicola Fabbri, Italy
|
| #42 |
Autobiological
Reconstruction With Preserved Joint Function After Surgical
Treatment Of Bone Sarcomas In Children
Örjan Berlin, Sweden
|
| #74 |
Endoprosthetic
Replacement Of Distal Humerus After Tumor Resection
Fabrice Fiorenza, France
|
| #26 |
Survivorship
Analysis Of 141 Modular Metallic Endoprostheses
Mark C. Gebhardt, USA
|
| #59 |
Low
Complication Rate With Limb-sparing Resection And Endoprosthetic
Reconstruction: Survival Analysis Of 251 Patients And Analysis
Of 20-year Experience
Felasfa M. Wodajo, USA
|
| #77 |
Is
There A Case For A Randomized Clinical Trial For Treatment
Of Giant Cell Tumours?
Robert Grimer, UK
|
| Diagnostic
Radiology |
| #27 |
Predictive
Value Of Gadolinium Enhancement In Differentiating Atypical
Lipomas (well-differentiated Liposarcomas) From Benign Fatty
Tumors
Matthew J. Panzarella, USA
|
| #61 |
Fdg-
Positron Emission Tomography (pet) In Staging And Managing
Patients With Soft Tissue Sarcomas
Thomas F. DeLaney, USA
|
| Medical
Oncology |
| #31 |
Fluorodeoxyglucose
Uptake In Adult Soft Tissue Sarcoma Predicts Risk Of Recurrence
After Chemotherapy
Scott M. Schuetze, USA
|
| #20 |
Randomised
Phase 3 Trial Of Two Investigational Schedules Of Ifosfamide
Versus Standard Dose Doxorubicin In Patients With Advanced
Or Metastatic Soft Tissue Sarcoma (asts)
Paul Lorigan, UK
|
| #30 |
Unexpected
Severe Toxicity Of Low Dose Metothrexate And Vinblastine In
Patients With Desmoid Tumours
Bert van Gel, The Netherlands
|
| #29 |
Phase
2 Trial With Imatinib (glivec, Sti571) In Patients With Gasto-intestinal
Stromal Tumors (gist): Activity Results After 1 Year. A Study
Of The Eortc Soft Tissue And Bone Sarcoma Group (stbsg)
Jaap Verweij, The Netherlands
|
#25
(YI)
|
Molecular
Targeting Of Pdgfb By Imatinib Mesylate In Dermatofibrosarcoma
Protuberans
Scott M. Schuetze, USA
|
| #57 |
Gleevec
Therapy In C-kit Negative Soft Tissue Sarcomas: A Molecular
Rationale
Dafydd Gareth Thomas, USA
|
|
Biology
|
| #73 |
Microarray
Analysis Of Malignant Fibrous Histiocytoma
Jay S. Wunder, Canada
|
| #24 |
Differential
Gene Expression In Leiomyosarcoma
Keith M. Skubitz, USA
|
| #35 |
Antisense
Inhibition Of Hyaluronan Synthase-2 In Human Osteosarcoma
Cell Line, Mg-63, Inhibits Hyaluronan Retention And Tumorigenicity
Of The Cells
Yoshihiro Nishida, Japan
|
#22
|
Neoplastic
Transformation Of Primary Human Osteoblasts Over-expressing
The Met Receptor By Means Of Transduction With Lentiviral
Vectors
Riccardo Ferracini, Italy
|
|
#71 (YI)
|
Targeting
Met Oncogene In Human Osteosarcoma By K-252a Tyrosine-kinase
Inhibitor: A New Therapeutic Approach
Sofia Avnet, Italy
|
| #46 |
Differential
Effects Of The Radioprotectant Amifostine On Ewing's Sarcoma
And Human Monocytes In Culture
Matthew J. Allen, USA
|
| Pathology |
| #49 |
Genome-wide
Analysis Of Gene Expression In Synovial Sarcoma Using A Cdna
Microarray
Junya Toguchida,Canada
|
| #17 |
Expression
Of The Ihh/pthrp And Bmp Receptors Has Diagnostic Relevance
In Cartilagineous Lesions
Luca Sangiorgi, Italy
|
| Pediatric
Oncology |
| #37 |
A
Randomized Trial Of Amifostine With High-dose Alkylator Therapy
In Ewing Sarcoma: A Children’s Oncology Group Trial (p9457)
Mark L. Bernstein, Canada
|
| Radiation
Oncology |
| #33 |
Higher
Postoperative Radiation Dose Improves The Local Control Rate
For Patients With Positive Surgical Margins And Locally Recurrent
Soft Tissue Sarcoma
Matthew T. Ballo, USA
|
| #76 |
Advantages
Of Proton Beams In Treatment Pelvic Sarcomas
Herman Suit, USA
|
